Ensysce Biosciences files Form 3 for President, Director James William Morrison

ENSC•2026-08-10

Form 3 filing for James William Morrison

Ensysce Biosciences President and director James William Morrison reported indirect holdings of Series C Non-Voting Convertible Preferred Stock convertible into 154,821,000 common shares.

Sources

Ensysce Biosciences files Form 3 for President, Director James William Morrison

Sec

Ensysce Biosciences files Form 3 for President, Director James William Morrison

Form 3 filing for James William Morrison

Related News

Hims & Hers able to scale peptide offering if US law allows, CFO says

First Advantage slides as Silver Lake to cut stake

Canadian miner Barrick falls after Q2 results

Sources

Ensysce Biosciences files Form 3 for President, Director James William Morrison

Upwork Q2 net income falls 22% on lower client, GSV base; issues soft Q3 revenue forecast

Fortune Brands EVP, Chief Supply Chain Matthew Novak sells 600 shares for $30,678